Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567)
Market Open
7 Aug, 06:57
SSE SSE Primary ¥
7. 08
+0.64
+9.9379%
¥
10.2B Market Cap
- P/E Ratio
0.8% Div Yield
132.42M Volume
- Eps
¥ 6.44
Previous Close Want to track 603567 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
603567 trading today higher at ¥7.08, an increase of 9.9379% from yesterday's close, completing a monthly increase of 59.4595% or ¥2.64. Over the past 12 months, 603567 stock lost -21.0702%.
603567 pays dividends to its shareholders, with the most recent payment made on Aug 20, 2025. The next estimated payment will be in In 1 weeks on Aug 20, 2026 for a total of ¥0.15.
The last earnings report, released on May 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Heilongjiang ZBD Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 13, 2016.
The company's stock is traded on one exchange.
603567 Chart
People also search for
Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567) FAQ
What is the stock price today?
The current price is ¥7.08.
On which exchange is it traded?
Heilongjiang ZBD Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 603567.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.8%.
What is its market cap?
As of today, the market cap is 10.2B.
Has Heilongjiang ZBD Pharmaceutical Co., Ltd. ever had a stock split?
Heilongjiang ZBD Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Jun 13, 2016.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jiujiang Yan CEO | SSE Exchange | CNE100002219 ISIN |
| CN Country | 2,545 Employees | 20 Aug 2025 Last Dividend | 13 Jun 2016 Last Split | - IPO Date |
Overview
Heilongjiang ZBD Pharmaceutical Co., Ltd., founded in 1996 and located in Hulin, China, is a distinguished entity in the Chinese pharmaceutical industry. The company is dedicated to the research, development, production, and sale of Chinese medicines, catering to the healthcare needs of China's vast population. With a focus on integrating traditional Chinese medicine practices with modern scientific research techniques, Heilongjiang ZBD Pharmaceutical Co., Ltd. aims to develop innovative and effective medical solutions for a wide range of diseases and health conditions.
Products and Services
- Cardiovascular and Cerebrovascular: Products focusing on the health of the heart and blood vessels, aiming to prevent, treat, and manage conditions such as hypertension, stroke, and coronary heart disease.
- Respiratory System: Medications designed to treat and manage respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, focusing on improving patients' breathing capabilities and overall lung health.
- Orthopedics: Treatments for bone, joint, and muscle conditions, including osteoporosis, arthritis, and traumatic injuries, aimed at enhancing mobility and reducing pain.
- Tumors: Medicinal solutions that contribute to the battle against cancer, focusing on both the direct treatment of tumors and the alleviation of symptoms associated with various cancers.
- Digestive System: Products tailored to address disorders of the gastrointestinal tract, such as gastritis, peptic ulcer disease, and inflammatory bowel disease, aiming to improve digestion and overall gut health.
- Anti-Infection: A range of antibiotics and antiviral medications designed to combat infectious diseases, ensuring effective treatment and prevention of further spread of infections.
- Mental Nerve: Treatments and therapies for disorders of the nervous system, including anxiety, depression, and neurological disorders, focusing on preserving and enhancing neurological function and mental well-being.
- Genitourinary: Medicines aimed at disorders of the genitourinary tract, such as urinary tract infections, erectile dysfunction, and kidney stones, designed to restore and maintain normal function and health.
- Other Disease Fields: A broad category that encompasses treatments for various other health conditions, underlining the company’s commitment to addressing the wide spectrum of healthcare needs faced by the population.
Contact Information
Address: No. 72 Hongxing Street, Hulin, China, 150060
Phone: 86 45 8681 1969
Website: https://www.zbdzy.com
